



Evaluation of Preliminary Criteria for Definite Disease 
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DENYS K. FORD, ARMIN E. GOOD, and ALFONSE T. MAS1 
A retrospective evaluation of 83 patients with 
Reiter’s syndrome (RS) and 166 comparison arthritis 
patients was conducted in order to assess the prelimi- 
nary criteria for definite RS. Data analysis was based on 
the statement that Reiter’s syndrome consists of an epi- 
sode of peripheral arthritis of more than 1 month dura- 
tion occurring in association with urethritis and/or cer- 
vicitis. During the initial episode of RS, 70 of the 83 R S  
patients satisfied the criteria, yielding a sensitivity of 
84.3%. 
The extensive overlap of clinical manifestations 
of the various seronegative spondylarthropathy syn- 
dromes makes it difficult to define a specific disease 
within that group of disorders (1). The discovery that 
HLA-B27 is found in a high proportion of such patients 
has helped to focus on the interrelationships of these 
disorders (2). 
This report describes an effort to define “defi- 
nite” Reiter’s syndrome by a retrospective evaluation of 
typical cases submitted from seven university-based ar- 
thritis centers. The investigation has been underway for 
a number of years, and selection of cases preceded 
knowledge of histocompatibility types. In a sense, the 
proposed criteria provide a clinical definition of a pa- 
tient group which may subsequently be recognized by 
other markers. 
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STUDY DESIGN 
Participating centers contributed specific protocol 
evaluations of patients in five disease categories: Reiter’s syn- 
drome (RS), ankylosing spondylitis (AS), seronegative rheu- 
matoid arthritis (SNRA), psoriatic arthritis (PsA), and gono- 
coccal arthritis (GcA). The patients selected were “typical” in 
the investigator’s experience. Sixty-six discrete variables (a se- 
lection is given in Table 1) believed by the investigators to 
have value in the discrimination and classification of RS were 
analyzed univariately for their presence or absence in Reiter’s 
syndrome patients by the Chi-square test and visual in- 
spection. Variables that seemed especially useful were exam- 
ined in four-way or less contingency tables to examine their 
power of classification. Multiple discriminant function analy- 
sis was also used to discriminate between the groups, and be- 
tween subjects with Reiter’s syndrome versus all other pa- 
tients. Previously proposed provisional criteria were modified 
on the basis of these results.* 
Urethritis is defined as a genitourinary inflammation 
with evidence of slight, moderate, or profuse mucopurulent or 
seropurulent discharge. If the discharge is scanty, it may be 
demonstrable only in the morning after urination. Dysuria 
may be found, often without discharge, and is indicative of re- 
cent cystitis or urethritis. Rarely and more problematical is 
the presence of only recent asymptomatic pyuria. If Reiter’s 
syndrome is accompanied by gonococcal urethritis, the ure- 
thral discharge may persist after the administration of an ade- 
quate dose of penicillin sufficient to eradicate the gonococci. 
* A previous subcommittee for the classification of Reiter’s 
syndrome of the American Rheumatism Association (ARA) Diagnos- 
tic and Therapeutic Criteria Committee had proposed that a diagnosis 
be established on the basis of the occurrence o f  certain clinical mani- 
festations. The designations of these manifestations were more clearly 
delineated by categorizing them as major and minor. Using these cri- 
teria, a diagnosis of definite Reiter’s syndrome could be made if three 
major manifestations occurred. An individual could be considered to 
have probable or incomplete RS if arthritis occurred within 3 to 6 
weeks after urethritis, with or without the presence of mucosal lesions. 
Alternately, probable disease was possible when one major and three 
minor criteria occurred within a 6-week period. 
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Table 1. 
the initial attack* 
Percentage of Reiter’s syndrome case and comparison patients with positive findings during 
YG RS % A S  %SNRA %PsA % GcA 
Sign or symptom (n = 83) (n = 53) (n = 33) (n = 53) (n = 27) 







Urethritis, males and females 
Cervicitis (number of females) 
Conjunctivitis, any 
Bilateral 










Duration of initial attack 
1 week or less 
1 week-1 month 
Longer than 1 month 
Positive family history 
HLA-B27 positive (number typed) 
Joint x-ray abnormalities 
Peripheral (number cases) 







































































































































46( 1 1) 
O(4) 
RS = Reiter’s syndrome; AS = ankylosing spondylitis; SNRA = seronegative definite rheumatoid ar- 
thritis; PsA = psoriatic arthritis; GcA = gonococcal arthritis. 
t CNS = central nervous system. 
Table 2. 
examination* 








Knees or ankles 
Heels 
Feet 
% RS % AS 






















(n = 31/51) 
‘70 GcA 



















Asymmetric involvement for 
tenderness and/or swelling 
Heels 32/10 0/8 5/14 6/7 2/- 
Feet 20/15 o/ 1 1/5 21/26 4/- 
* RS = Reiter’s syndrome; AS = ankylosing spondylitis; SNRA = seronegative definitive arthritis; PsA = 
psoriatic arthritis; GcA = gonococcal arthritis. 
t % during initial episode/% during final examination. 
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Table 3. 
typical Reiter’s syndrome 
Percent sensitivity and specificity of proposed criteria for 
Number correctly 
classified/ 
Percent number tested 
~ ~~ ~~ 
Sensitivity 
At initial episode 84.3 70/83 
Including subsequent attacks 97.6 81/83 
Specificity against* 
All other cases 98.2 1631 I66 
Ankylosing spondylitis 96.2 51/53 
Seronegative definite rheu- 
matoid arthritis 100.0 33/33 
Psoriatic arthritis 100.0 53/53 
Gonococcal arthritis 96.3 26/27 
* Initial episode. 
The mucocutaneous lesions of Reiter’s syndrome may 
be keratodermia blennorrhagicum, balanitis circinata sicca, or 
oral mucosal lesions. Keratodermia blennorrhagicum usually 
begins on the palms and soles as pustules. Gradually they be- 
come covered with thick, horny crusts. Neighboring lesions 
may become confluent, and similar lesions can develop on all 
cutaneous areas. Clinically, cutaneous lesions are difficult to 
differentiate from pustular psoriasis. 
RESULTS 
Two hundred forty-nine protocols on case and 
comparison patients were submitted from seven cen- 
ters* and analyzed for 66 variables. A selection of these 
variables is shown in Table 1; percentage may be based 
upon data which were not complete in all cases. Disease 
manifestations of RS such as myocarditis were eval- 
uated, although no patients in any of the disease cate- 
gories studied were found to have this variable. 
Virtually all 249 patients had peripheral or spi- 
nal arthritis as a component of their initial attack. Poly- 
articular presentation, i.e. four or more joints involved, 
greatly exceeded monarticular onset. 
Diffuse swelling of a toe, the classic “sausage 
digit” (or dactylitis), occurred in 17% of RS patients, 
but the frequency was much greater (52%) in patients 
with psoriatic arthritis. An acute attack of disease had 
occurred in 75% of patients with RS, all of those with 
GcA, and 32% of those with SNRA. 
Articular tenderness and/or swelling was as- 
sessed to determine the regions of the body involved 
and symmetry (Table 2). Involvement of the knees or 
* University of Washington, Stanford University, Johns 
Hopkins University, University of British Columbia, University of 
Michigan, University of Tennessee, Centre for the Health Sciences, 
University of Lausanne in Switzerland, New York University. 
Table 4. 
typical Reiter’s syndrome* 
Percent sensitivity and specificity of various criteria for 
Method of classification Sensitivityt Specificity? 
1. Episode of arthritis of more 
than 1 month with urethritis 
and/or cervicitis 
2. Episode of arthritis of more 
than 1 month and either 
urethritis or cervicitis, or 
bilateral conjunctivitis 
3. Episode of arthritis, con- 
junctivitis, and urethritis 
4. Episode of arthritis of more 














* Initial episode. 
t Numbers in parentheses indicate number of patients correctly classi- 
fied/number tested. 
ankles occurred in 61% of the RS patients in their initial 
attack, and heels were swollen or tender in 26%. Heel 
involvement was asymmetric in 32% of RS patients in 
whom it occurred. Asymmetric involvement of joints 
was not a distinguishing characteristic of the arthritis of 
RS in comparison to the other diseases studied. 
The data analysis was simplified by the proposal 
that Reiter’s syndrome consists of an episode of peripheral 
arthritis of more than I month duration occurring in asso- 
ciation with urethritis and/or cervicitis. Other more com- 
plex combinations were considered less helpful. 
Table 3 indicates the sensitivity and specificity of 
the proposed criteria. Sensitivity is the percentage of ac- 
cepted RS cases that satisfy criteria, and specificity is 
the percentage of comparison patients who do not sat- 
isfy criteria. During the initial episode, 70 of the 83 Rei- 
ter’s patients satisfied criteria yielding a sensitivity of 
84.3%. Of the 13 RS patients incorrectly classified, 1 
Table 5. Percentages of specified signs and symptoms present 
during the initial episode of Reiter’s syndrome among patients who 
did and did not satisfy proposed criteria 








% RS patients 
satisfying 
criteria 
(n = 70) 
% RS patients 
not satisfying 
criteria 
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Table 6. Secondary signs and symptoms associated with Reiter’s syndrome and comparison diseases* 
Reiter’s syndrome 
Seronegative 
Number Criteria Criteria Ankylosing rheumatoid Psoriatic Gonococcal 
present positive negative spondylitis arthritis arthritis arthritis 
6 5 0 0 0 0 0 
5 4 0 0 0 I 0 
4 10 0 0 0 0 0 
3 1 1  I 1 0 0 0 
2 10 1 0 2 3 4 
I 14 4 10 1 3 7 
0 9 7 42 30 46 15 
* Signs and symptoms are: bilateral eye involvement, fever, weight loss, heel pain, balanitis, and mucous 
membrane lesions. 
male had a duration of initial episode of 2 to 4 weeks. 
The other 11 males did not have urethritis. In 11 of the 
13 individuals, a subsequent attack of arthritis and ure- 
thritis occurred. The duration of the subsequent attack 
or attacks was not assessed, but if one assumes an epi- 
sode enduring more than 1 month, 81 of 83 Reiter’s pa- 
tients would be correctly classified during the course of 
Alternative criteria were considered which in- 
cluded the classic definition of RS as the triad of arthri- 
tis, urethritis, and conjunctivitis, with and without de- 
fining time limits. Comparison of the sensitivity and 
specificity of alternative criteria is shown in Table 4. 
Three comparison patients were misclassified us- 
ing the proposed criteria. Two of them were entered as 
having ankylosing spondylitis; both of these patients 
had unilateral conjunctivitis and heel pain, as well as 
satisfying the criteria for RS. The third patient with 
GcA satisfied the criteria, as well as displaying heel pain 
and fever. The specificity of the criteria was 98.2% dur- 
ing the initial episode. 
followup. 
at 59 hospitals and clinics were involved in contributing 
retrospective protocol data to that study. 
A more critical analysis is one in which criteria 
are derived from predefined prospectively gathered 
data, and the patients are followed for a sufficient pe- 
riod to confirm the study diagnosis and document the 
natural history or prognosis of the disease, e.g., the re- 
cent study of classification criteria for systemic sclerosis 
(scleroderma) (5). 
Inherent difficulties exist in accomplishing such a 
study in RS and the control diseases from which it must 
be differentiated. For example, the disease may be tran- 
sient, long-term followup is difficult, symptoms and 
signs may be temporally spaced, and radiographic 
changes are usually not apparent until later in the dis- 
ease course (6). For these reasons, we chose to evaluate 
case records of “typical” patients in an attempt to de- 
velop initial criteria for definite RS. 
To derive the criteria, detailed search for disease 
Table 7. 
tions according to B27 positivity or negativity 
Proportion of Reiter’s patients having selected manifesta- 
DISCUSSION 
The development of criteria in the rheumatic dis- 
eases has followed an evolution in concept and appli- 
cation. The criteria for rheumatoid arthritis, for ex- 
ample, were developed and proposed by a small group 
of physicians on the basis of their clinical experience 
(3). Limited testing of those criteria was undertaken 
prior to their suggested acceptance. This contrasts with 
the method used to arrive at the 14 criteria now pro- 
posed for the classification of systemic lupus erythema- 
tosus (SLE) (4). The criteria for SLE are based on a crit- 
ical analysis of 245 patients with unequivocal SLE, 204 
with probable SLE, and 451 patients with rheumatoid 
arthritis and other disorders. Fifty-two rheumatologists 
Selected Positive Negative 
manifestations (n = 63)* (n = 1 l)t P value.+ 
Urethritis 5 1/62 10/11 NS 
Conjunctivitis 34/63 7/11 NS 
Mucous membrane 14/54 3/10 NS 
5/11 NS 
Polyarticular arthritis 25/59 54 63 7/11 NS 
Heel pain 
Sacroiliac involvement, 
Last exam 15/46 2/9 NS 
Skin lesions 31/59 2/10 0.045 
Weight loss 22/55 2/9 NS 
Fever 18/55 4/9 NS 
* Number B27 positive/number with manifestations. 
t Number B27 negative/number with manifestations. 
$ Chi-square analysis with continuity correction. NS = not signifi- 
cant. 
8 Two-sided Fischer’s exact test. 
x-ray (initial episode) 6/29 0/4 NS§ 
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patterns utilized both clinical intuition and computer 
assistance, e.g. discriminant function analysis programs. 
None of the more complex definitions was superior in 
classification ability to the one proposed. This being the 
case, the simplest classification criteria were selected. 
These criteria do not negate the importance in diagnosis 
of a variety of signs and symptoms which commonly oc- 
cur in Reiter’s syndrome. The other manifestations usu- 
ally occur at the same time as the appearance of urethri- 
tis and/or cervicitis. 
Table 5 indicates the percentage of selected signs 
and symptoms which occur in RS. Patients meeting the 
proposed criteria had higher percentages of these dis- 
ease manifestations. 
Table 6 makes the same point in a different fash- 
ion. The number of patients with different combinations 
of the six specified signs and symptoms were deter- 
mined for each disease category. For example, 10 AS 
patients manifested only one of the six features. The RS 
patients satisfying the criteria had significantly more 
manifestations (an average of 2.4) than those not meet- 
ing the criteria (an average of 0.7). Secondly, 40% of the 
RS patients had three or more clinical findings, while 
only 1.8% of the comparison patients had three or more. 
Clearly these manifestations predominate in RS, espe- 
cially in those patients who satisfy the proposed criteria. 
Roentgenographic findings were part of an ear- 
lier set of proposed criteria, but they were found to be of 
no help in the diagnosis of an acute episode of RS. Data 
on sacroiliac joint involvement subsequent to the initial 
episode were reviewed. Of 13 RS patients presenting 
with fever, 44.3% later developed sacroiliitis versus 
24.3% of 33 patients who did not have fever initially. 
These data are not statistically significant, but fever and 
other systemic manifestations merit critical attention in 
long-term studies of patients with RS (6). 
The occurrence of selected clinical manifesta- 
tions was analyzed in relation to the presence or ab- 
sence of HLA-B27 positivity (Table 7). Little difference 
was found, although B27 positivity was associated with 
more frequent skin lesions (P = 0.04) and possibly with 
more frequent weight loss (P = 0.09). With the small 
number of HLA-B27 negative cases studied, it is diffi- 
cult to demonstrate such differences. 
Twelve of the 13 patients not fulfilling the cri- 
teria had arthritis. Five of these individuals had second- 
ary manifestations, and all but 1 was HLA-B27 posi- 
tive. One patient with a disease episode of less than 1 
month which was characterized by urethritis, arthritis, 
and conjunctivitis was B27 negative. Although asym- 
metric lower extremity involvement occurred frequently 
in RS, Table 2 shows similar distribution in SNRA. 
This retrospective evaluation of 83 typical RS 
patients and 166 comparison arthritis patients has pro- 
vided a characterization of the initial attack of what 
might be considered definite RS. Such clinical syn- 
dromes can be distinguished with increasing confidence, 
depending upon the extent of associated manifestations 
other than arthritis of longer than 1 month duration and 
urethritis or cervicitis. 
This report has not thoroughly addressed the is- 
sue of RS patients who do not fulfill the primary criteria 
nor the issue of other forms of reactive arthritis which 
mimic RS. These important questions will require more 
extensive prospective and immunogenetic correlation. 
The problem of recognizing the patient with long 
established RS who may now be diagnosed as having 
AS or PsA (7) or the individual with reactive arthropa- 
thy alone is not satisfactorily addressed by this study. 
The categories of incomplete Reiter’s syndrome (6),  re- 
active arthritis (8), ankylosing spondylitis, psoriatic ar- 
thritis, and seronegative rheumatoid arthritis probably 
represent heterogenous patient groupings. These classi- 
fications are being examined by other groups of investi- 
gators (9,lO). 
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